VYKTRA Trademark

Trademark Overview

On Friday, March 2, 2001, a trademark application was filed for VYKTRA with the United States Patent and Trademark Office. The USPTO has given the VYKTRA trademark a serial number of 78051124. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, August 11, 2006. This trademark is owned by PHARMACIA CORPORATION. The VYKTRA trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER, CARDIOVASCULAR CONDITIONS AND SEPSIS

General Information

Serial Number78051124
Word MarkVYKTRA
Filing DateFriday, March 2, 2001
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateFriday, August 11, 2006
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 25, 2001

Trademark Statements

Goods and ServicesPHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER, CARDIOVASCULAR CONDITIONS AND SEPSIS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 7, 2001
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePHARMACIA & UPJOHN COMPANY LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressPEAPACK, NJ 07977
Party NamePHARMACIA CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPEAPACK, NJ 07977
Party NamePHARMACIA CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPEAPACK, NJ 07977

Trademark Events

Event DateEvent Description
Thursday, October 12, 2006ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Thursday, October 12, 2006ABANDONMENT - NO USE STATEMENT FILED
Monday, January 23, 2006EXTENSION 4 GRANTED
Monday, January 23, 2006EXTENSION 4 FILED
Monday, January 23, 2006TEAS EXTENSION RECEIVED
Friday, June 24, 2005EXTENSION 3 GRANTED
Friday, June 24, 2005EXTENSION 3 FILED
Friday, June 24, 2005TEAS EXTENSION RECEIVED
Wednesday, June 22, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 28, 2004EXTENSION 2 GRANTED
Tuesday, December 28, 2004EXTENSION 2 FILED
Tuesday, December 28, 2004TEAS EXTENSION RECEIVED
Tuesday, December 28, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 3, 2004EXTENSION 1 GRANTED
Friday, July 16, 2004EXTENSION 1 FILED
Friday, July 16, 2004TEAS EXTENSION RECEIVED
Monday, June 21, 2004CASE FILE IN TICRS
Tuesday, February 10, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 9, 2003OPPOSITION TERMINATED NO. 999999
Tuesday, December 9, 2003OPPOSITION TERMINATED NO. 999999
Tuesday, December 9, 2003OPPOSITION DISMISSED NO. 999999
Monday, March 31, 2003PAPER RECEIVED
Monday, November 18, 2002TEAS CORR ADDRESS REQUEST RECEIVED BUT NOT PROCESSED STAT IS TTAB
Friday, April 26, 2002OPPOSITION INSTITUTED NO. 999999
Tuesday, October 16, 2001EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, September 25, 2001PUBLISHED FOR OPPOSITION
Wednesday, September 5, 2001NOTICE OF PUBLICATION
Tuesday, July 3, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 3, 2001EXAMINERS AMENDMENT MAILED
Monday, July 2, 2001PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, June 27, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 27, 2001EXAMINERS AMENDMENT MAILED
Wednesday, May 2, 2001NON-FINAL ACTION MAILED
Wednesday, March 21, 2001ASSIGNED TO EXAMINER
Wednesday, March 21, 2001PETITION TO DIRECTOR - GRANTED
Monday, March 12, 2001PETITION TO DIRECTOR RECEIVED

Related Keywords

vyktra conditions sepsis cardiovascular cancer preparations treatment pharmaceutical